Go Pro

Crinetics Pharmaceuticals (CRNX) Insider Trading & Ownership

Crinetics Pharmaceuticals logo
$42.23 +3.55 (+9.18%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$42.56 +0.33 (+0.77%)
As of 07/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Crinetics Pharmaceuticals (NASDAQ:CRNX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$8.37M
Get CRNX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crinetics Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRNX Insider Buying and Selling by Quarter

Crinetics Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/17/2026Sell6,900$35.67$246,123.00  
4/8/2026Sell85,163$40.10$3,415,036.30  
3/16/2026Sell9,911$37.37$370,374.07  
3/16/2026Sell21,981$37.37$821,429.97  
3/16/2026Sell10,612$37.37$396,570.44  
3/12/2026Sell5,000$36.15$180,750.00  
3/3/2026Sell3,000$39.67$119,010.00  
3/3/2026Sell6,713$39.67$266,304.71  
3/3/2026Buy$40.12$1,001 - $15,000
1/5/2026
Isabel Kalofonos
Insider
Sell2,500$55.00$137,500.00  
11/3/2025Sell5,000$42.66$213,300.00  
Trump's gold order: the announcement they won't put on the front page (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
10/1/2025Sell5,000$41.81$209,050.00  
9/26/2025Sell16,000$44.75$716,000.00  
9/26/2025Sell4,000$45.00$180,000.00  
8/22/2025Sell30,000$30.43$912,900.00  
8/20/2025Sell6,492$29.18$189,436.56  
(Data available from 1/1/2013 forward)

CRNX Insider Trading Activity - Frequently Asked Questions

3.80% of Crinetics Pharmaceuticals stock is owned by insiders. Learn more on CRNX's insider holdings.

The following insiders have sold CRNX shares in the last 24 months: Coelho Rogerio Vivaldi ($180,750.00), Dana Pizzuti ($3,236,362.06), Isabel Kalofonos ($137,500.00), James Hassard ($661,200.00), Jeff E Knight ($5,543,667.29), Marc Wilson ($3,679,487.28), Matthew K Fust ($716,000.00), Richard Scott Struthers ($1,594,389.57), Stephanie Okey ($365,133.00), Stephen F Betz ($4,057,260.03), and Tobin Schilke ($266,304.71).

Insiders have sold a total of 498,112 Crinetics Pharmaceuticals shares in the last 24 months for a total of $20,438,053.94 sold.

Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of Crinetics Pharmaceuticals in the last year totaling $8,000.



This page (NASDAQ:CRNX) was last updated on 7/3/2026 by MarketBeat.com Staff.
From Our Partners